ARS Pharmaceuticals, Inc.

Healthcare · Biotechnology · United States

Last price 3.66 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 363.98M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.